Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.24
+0.11 (2.14%)
At close: Oct 27, 2025, 4:00 PM EDT
5.10
-0.14 (-2.67%)
Pre-market: Oct 28, 2025, 8:51 AM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $92.55 million as of October 28, 2025. Its market cap has increased by 171.02% in one year.
Market Cap
92.55M
Enterprise Value
70.63M
1-Year Change
171.02%
Ranking
Category
Stock Price
$5.24
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $92.55M, an increase of 39.19%. That is a compound annual growth rate of 8.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 90.60M | 9.91% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |